ATE370236T1 - Nukleinsäure- und polypeptidfragmente von m. tuberculosis - Google Patents

Nukleinsäure- und polypeptidfragmente von m. tuberculosis

Info

Publication number
ATE370236T1
ATE370236T1 AT04076605T AT04076605T ATE370236T1 AT E370236 T1 ATE370236 T1 AT E370236T1 AT 04076605 T AT04076605 T AT 04076605T AT 04076605 T AT04076605 T AT 04076605T AT E370236 T1 ATE370236 T1 AT E370236T1
Authority
AT
Austria
Prior art keywords
tuberculosis
nucleic acid
polypeptide fragments
polypeptides
proteins
Prior art date
Application number
AT04076605T
Other languages
German (de)
English (en)
Inventor
Peter Andersen
Walter Florio
Thomas Oettinger
Peter Birk Rasmussen
Ida Rosenkrands
Rikke Louise Vinther Skjoet
Karin Weldingh
Original Assignee
Statens Seruminstitut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Seruminstitut filed Critical Statens Seruminstitut
Application granted granted Critical
Publication of ATE370236T1 publication Critical patent/ATE370236T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT04076605T 1997-04-02 1998-04-01 Nukleinsäure- und polypeptidfragmente von m. tuberculosis ATE370236T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK37697 1997-04-02
US4462497P 1997-04-18 1997-04-18
DK127797 1997-11-10
US7048898P 1998-01-05 1998-01-05

Publications (1)

Publication Number Publication Date
ATE370236T1 true ATE370236T1 (de) 2007-09-15

Family

ID=47018662

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04076605T ATE370236T1 (de) 1997-04-02 1998-04-01 Nukleinsäure- und polypeptidfragmente von m. tuberculosis

Country Status (10)

Country Link
EP (2) EP0972045A1 (enExample)
JP (4) JP4172598B2 (enExample)
AT (1) ATE370236T1 (enExample)
AU (1) AU740545B2 (enExample)
CA (1) CA2285625C (enExample)
DE (1) DE69838268T2 (enExample)
DK (1) DK1449922T3 (enExample)
ES (1) ES2291810T3 (enExample)
PT (1) PT1449922E (enExample)
WO (1) WO1998044119A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6991797B2 (en) 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US7037510B2 (en) 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
CA2319380A1 (en) * 1997-11-10 1999-05-20 Statens Serum Institut Nucleic acid fragments and polypeptide fragments derived from m. tuberculosis
NZ507278A (en) * 1998-03-06 2003-10-31 Statens Seruminstitut Production of mycobacterial polypeptides by lactic acid bacteria
AU2594500A (en) * 1998-12-24 2000-07-31 Corixa Corporation Methods for using mycobacterium tuberculosis molecules as immunological adjuvants
US7932373B1 (en) * 1999-05-04 2011-04-26 University Of Medicine And Dentistry Of New Jersey Proteins expressed by mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines
US6537552B1 (en) 1999-10-19 2003-03-25 Iowa State University Research Foundation Vaccine adjuvant
WO2001079274A2 (en) * 2000-04-19 2001-10-25 Statens Serum Institut Tuberculosis antigens and methods of use thereof
US7288261B2 (en) * 2000-07-10 2007-10-30 Colorado State University Research Foundation Mid-life vaccine and methods for boosting anti-mycobacterial immunity
WO2004099771A1 (en) * 2003-05-08 2004-11-18 Statens Serum Institut A new specific epitope based immunological diagnosis of tuberculosis
JP4838259B2 (ja) 2004-11-16 2011-12-14 クルセル ホランド ベー ヴェー 組み換えウイルスベクターを含む多価ワクチン
EP2397855A3 (en) 2006-03-14 2012-03-14 Oregon Health and Science University Methods for detecting a mycobacterium tuberculosis infection
GB0618127D0 (en) * 2006-09-14 2006-10-25 Isis Innovation Biomarker
WO2008140478A2 (en) * 2006-11-01 2008-11-20 Immport Therapeutics, Inc. Compositions and methods for immunodominant antigens
CN106421743A (zh) * 2009-07-29 2017-02-22 贝恩德·赫尔穆特·阿达姆·雷姆 聚合物微粒及其用途
WO2011159814A2 (en) * 2010-06-15 2011-12-22 The Regents Of The University Of California Novel live recombinant booster vaccine against tuberculosis
JP2015515276A (ja) * 2012-04-16 2015-05-28 アエラス グローバル ティービー ワクチン ファウンデーション ヘパリン結合性赤血球凝集素(hbha)融合タンパク質とその用途をコードする組換え型マイコバクテリウム
CN104897838B (zh) * 2015-06-10 2016-08-17 重庆医科大学 一种强极性有机酸碱混合物的同时提取分离分析方法
US20220213461A1 (en) * 2019-05-07 2022-07-07 Nanyang Technological University Asx-specific protein ligases and uses thereof
CN113373162A (zh) * 2020-03-09 2021-09-10 北京蛋白质组研究中心 结核分枝杆菌H37Rv新基因Rv0229A及其编码蛋白和应用
AU2021258911A1 (en) * 2020-04-20 2022-11-24 The University Of British Columbia Compositions and methods for preventing, controlling and diagnosing mycobacterial infections
CN116082514B (zh) * 2021-11-05 2024-02-13 安博智联(北京)生物科技有限公司 结核分枝杆菌特异性的重组融合蛋白em及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK79893D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut New vaccine
AU6024596A (en) * 1995-05-23 1996-12-11 Regents Of The University Of California, The Abundant extracellular products and methods for their production and use
BR9610262B1 (pt) * 1995-09-01 2013-11-26 Compostos e métodos para a imunoterapia e diagnose de tuberculose.
PT2154248E (pt) * 1995-09-01 2012-01-16 Corixa Corp Compostos e métodos para diagnóstico de tuberculose

Also Published As

Publication number Publication date
EP1449922A3 (en) 2004-11-17
JP2001515359A (ja) 2001-09-18
DE69838268D1 (de) 2007-09-27
DE69838268T2 (de) 2008-05-08
AU740545B2 (en) 2001-11-08
JP2008301817A (ja) 2008-12-18
JP2010154856A (ja) 2010-07-15
WO1998044119A1 (en) 1998-10-08
ES2291810T3 (es) 2008-03-01
CA2285625A1 (en) 1998-10-08
EP1449922B1 (en) 2007-08-15
AU6820498A (en) 1998-10-22
PT1449922E (pt) 2007-11-09
JP2008142079A (ja) 2008-06-26
JP4406024B2 (ja) 2010-01-27
EP0972045A1 (en) 2000-01-19
DK1449922T3 (da) 2007-12-03
EP1449922A2 (en) 2004-08-25
CA2285625C (en) 2015-06-30
JP4544434B2 (ja) 2010-09-15
JP4172598B2 (ja) 2008-10-29

Similar Documents

Publication Publication Date Title
ATE370236T1 (de) Nukleinsäure- und polypeptidfragmente von m. tuberculosis
DE69838334D1 (de) Kdr, ein menschlicher tyrosin kinase rezeptor
WO2001079274A3 (en) Tuberculosis antigens and methods of use thereof
DK1218751T3 (da) Cöliakidiagnose under anvendelse af et gliadinepitop
PT85977A (en) Process for the preparation of human apolipoprotein ai and their variant forms by recombinant dna methods
NZ502391A (en) Mammalian cytokine: interleukin-B30 and related reagents
DE69034100D1 (de) Verktorvermittelte genominsertion und expression von dna in bcg
DK645887D0 (da) Gamma-hesteinterferon, fremgangsmaade til fremstilling af, samt anvendelse af en saadan forbindelse
DK0975755T3 (da) CRSP-protein (cysteinrige udskilte proteiner), nukleinsyremolekyler der koder herfor samt anvendelser deraf
DK491487D0 (da) Dna-sekvens til ekspressionering af biologisk aktivt faktor xiii og anvendelse af samme
DK1025237T3 (da) Human kontrolpunktskinase, hCDS1, præparater og fremgangsmåder
SE9402089D0 (sv) Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments
DE69840445D1 (de) Antigen-konstrukte, für den nachweis und die unterscheidung von antikörpern gegen hiv
ATE270333T1 (de) Von proteinen des hepatitis c-virus abgeleitete polypeptide und deren verwendung
DE3877136D1 (de) Rekombinantes histidinreiches protein von plasmodium falciparum, seine herstellung und verwendung.
WO1997008317A3 (en) Human hypothalmic ('hr') receptor polypeptide compositions, methods and uses thereof
DK1241186T4 (da) Humant vækststandsende specifikt gen-6 (gas-6) og nukleinsyrer kodende derfor
FI870501L (fi) Menetelmä melanoomaan liittyvän p97-antigeenin antigeenisen sukulaispeptidin tai -proteiinin valmistamiseksi, sekä siinä käyttökelpoiset yhdistelmävirukset, yhdistelmävektorit ja isäntäsolut
DE3876227D1 (de) Malaria-spezifische dna-sequenzen, ihre expressionsprodukte und deren verwendung.
DE69943058D1 (de) Loslösendes protein 5 - ucp5
BR0213029A (pt) Receptor acoplado por proteìna g, gave10
WO2001070774B1 (en) Human t cell response to mhc-binding motif clusters
DE69829417D1 (de) Polypeptide und dafür kodierende Nukleinsäure
ATE405590T1 (de) Menschliches hcar-ähnliches protein und dafür kodierende nukleinsäure
EP0953642A4 (en) ANTIGENIC PROTEIN DRAWN FROM THE INFECTIOUS LARYNGO-TRACHEITIS VIRUS

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1449922

Country of ref document: EP